Fenoget®

Therapeutic Segment:

Anti-hyperlipidemic

Generic Name:

Fenofibrate

Indication

Capsules
  • 67MG
  • 200MG

For:

  • Primary Hypercholesterolemia and Mixed Dyslipidemia as adjunctive therapy to diet to
    reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG), and apolipoprotein B (Apo B), and to increase high-density lipoprotein cholesterol (HDL-C) in adult patients with primary hyperlipidemia or mixed dyslipidemia.
  • Hypertriglyceridemia as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia.